We are live on
!
Find out more
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
0 hedge funds and large institutions have $0 invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $2.98M → $0 (-$2.98M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
-$2.93M |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$51.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$2.93M | -17,000 | Closed |
|
|
IA
2
IFP Advisors
Tampa,
Florida
| – | -$51.7K | -300 | Closed |
|